Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genzyme rivals unleash barrage of promising Gaucher data
Fierce Biotech
Friday, February 12, 2010 - 9:04am
tags:
Genzyme, Gaucher disease, Shire, Protalix BioTherapeutics
Former Schering CEO Hassan Sees More Deals Among Drugmakers
Bloomberg
Friday, February 12, 2010 - 9:02am
tags:
Schering Plough, Fred Hassan, M&A
China Amends Patent Law For Compulsory Licensing
Pharmalot
Friday, February 12, 2010 - 8:23am
tags:
licensing, China, patents
Call-Selling in Vanda Pharma
Seeking Alpha
Friday, February 12, 2010 - 8:22am
tags:
Vanda
Biotech Stock Mailbag: NexMed
TheStreet.com
Friday, February 12, 2010 - 8:19am
tags:
NexMed, Sequenom, Vivus, Keryx, Targacept, Immunogen, Cell Therapeutics
AstraZeneca Says ‘Don’t Judge’ Earnings for Payoff
Bloomberg
Friday, February 12, 2010 - 8:15am
tags:
David Brennan, AstraZeneca, earnings
Roche moleculor diagnostics unit sues Qiagen unit
Reuters
Friday, February 12, 2010 - 8:14am
tags:
Roche, Qiagen
Simcere Wins OK for Flu Drug Relenza
Seeking Alpha
Friday, February 12, 2010 - 8:08am
tags:
Simcere, Flu, RELENZA, GSK
Cephalon fourth-quarter profit jumps to $96.6 mln
Marketwatch
Friday, February 12, 2010 - 8:06am
tags:
Cephalon, earnings
Drugmaker Deal-Negotiator Tauzin to Step Down From Trade Group
Bloomberg
Friday, February 12, 2010 - 8:04am
tags:
Billy Tauzin, PhRMA
Abbott gets approval for new formula of HIV drug
Yahoo/AP
Friday, February 12, 2010 - 8:03am
tags:
HIV, Abbott Laboratories, Norvir
Investors Are Sick Of Boston Scientific
Forbes
Friday, February 12, 2010 - 8:03am
tags:
Boston Scientific
Safety Concerns Continue to Dog Isis, Genzyme Partnership
Seeking Alpha
Thursday, February 11, 2010 - 3:55pm
tags:
Genzyme, Isis Pharmaceuticals, partnerships, mipomersen
No generics push for AZ, Brennan says
Fierce Pharma
Thursday, February 11, 2010 - 3:50pm
tags:
AstraZeneca, generics, Pharma CEOs, David Brennan
Sanofi's Sleight of Hand
WSJ Online
Thursday, February 11, 2010 - 3:48pm
tags:
Sanofi, earnings
Abbott gets European clearance for Solvay deal
Yahoo/AP
Thursday, February 11, 2010 - 3:46pm
tags:
Abbott Laboratories, Europe, M&A, Solvay
Drug Stocks Offer Big Yields, Long-Term Investment Opportunities
Seeking Alpha
Thursday, February 11, 2010 - 2:32pm
tags:
Abbott Laboratories, AstraZeneca, GSK, Bristol-Myers Squibb, JNJ, Eli Lilly, Merck, Novartis, Pfizer, Simcere, Tongjitang Chinese Medicines
[video] News Hub: Novartis 'Squeezes' Alcon Shareholders [3.4 min]
Marketwatch
Thursday, February 11, 2010 - 2:31pm
tags:
Alcon, Novartis
Drug stocks retreat; Alexza rebounds
Marketwatch
Thursday, February 11, 2010 - 12:26pm
tags:
drug stocks, Alexza
Cell Therapeutics pares Q4 loss
Bizjournals.com
Thursday, February 11, 2010 - 12:24pm
tags:
Cell Therapeutics, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.